Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-25

Clinical Trial Update: Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System [NA]

View source ↗

Summary

A post-approval study for the Hintermann Series H3 Total Ankle Replacement System is currently recruiting to assess outcomes in ankle osteoarthritis, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hintermann Series H3 Total Ankle Replacement System

Snippet

Sponsor: DT MedTech, LLC | Conditions: Osteoarthritis Ankle, Post-Traumatic Osteoarthritis of Ankle | NA | Status: RECRUITING